Evidence map›Paper›PMID 41183183›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

From sequence to scaffold: Computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks.

Cyrus M Haas, Naveen Jasti, Annie Dosey, Joel D Allen, Rebecca Gillespie, Jackson McGowan, Elizabeth M Leaf, Max Crispin, Cole A DeForest, Masaru Kanekiyo and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Cyrus M Haas *Department of Chemical Engineering, University of Washington, Seattle, WA 98195.ORCID 0000-0002-2204-9847
Naveen Jasti *Institute for Protein Design, University of Washington, Seattle, WA 98195.
Annie DoseyInstitute for Protein Design, University of Washington, Seattle, WA 98195.
Joel D AllenSchool of Biological Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom.ORCID 0000-0003-2547-968X
Rebecca GillespieVaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892.
Jackson McGowanInstitute for Protein Design, University of Washington, Seattle, WA 98195.
Elizabeth M LeafInstitute for Protein Design, University of Washington, Seattle, WA 98195.ORCID 0000-0002-5354-6010
Max CrispinSchool of Biological Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom.ORCID 0000-0002-1072-2694
Cole A DeForestDepartment of Chemical Engineering, University of Washington, Seattle, WA 98195.ORCID 0000-0003-0337-3577
Masaru KanekiyoVaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892.ORCID 0000-0001-5767-1532
Neil P KingInstitute for Protein Design, University of Washington, Seattle, WA 98195.ORCID 0000-0002-2978-4692

Funding

Structure-based design of broadly protective coronavirus vaccinesP01AI167966 · NIAID · UNIVERSITY OF WASHINGTON · PI BALI PULENDRAN · 2022 to 2026
$15.3M
Gates Foundation INV-008813Gates Foundation INV-010680Gates Foundation INV-043758HHS | NIH (NIH) P01AI167966NIAID NIH HHS P01 AI167966
6 · The paper itself

Abstract

Self-assembling protein nanoparticles are being increasingly utilized in the design of next-generation vaccines due to their ability to induce antibody responses of superior magnitude, breadth, and durability. Computational protein design offers a route to nanoparticle scaffolds with structural and biochemical features tailored to specific vaccine applications. Although strategies for designing self-assembling proteins have been established, the recent development of powerful machine learning (ML)-based tools for protein structure prediction and design provides an opportunity to overcome several of their limitations. Here, we leveraged these tools to develop a generalizable method for designing self-assembling proteins starting from AlphaFold2 predictions of oligomeric protein building blocks. We used the method to generate six 60-subunit protein nanoparticles with icosahedral symmetry, and single-particle cryoelectron microscopy reconstructions of three of them revealed that they were designed with atomic-level accuracy. To transform one of these nanoparticles into a functional immunogen, we reoriented its termini through circular permutation, added a genetically encoded oligomannose-type glycan, and displayed a stabilized trimeric variant of the influenza hemagglutinin receptor-binding domain through a rigid de novo linker. The resultant immunogen elicited potent receptor-blocking and neutralizing antibody responses in mice. Our results demonstrate the practical utility of ML-based protein modeling tools in the design of nanoparticle vaccines. More broadly, by eliminating the requirement for experimentally determined structures of protein building blocks, our method dramatically expands the number of starting points available for designing self-assembling proteins.

Indexed as

Computational BiologyNanoparticlesVaccinesAnimalsCryoelectron MicroscopyHemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesMachine LearningMiceModels, MolecularNanovaccinesHemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesNanovaccinesVaccinesinfluenzamachine learningnanoparticlesprotein designvaccines

Identifiers

PMID41183183
PMCPMC12626006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.